secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K/A
Filed at:   2026-05-21T20:40:52+00:00
Accession:  0001628280-26-037340
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SkinHealth terminates CRO Ronald Menezes without cause; $463K severance granted
-------------------------------------------------------------------------------

- Termination effective May 6, 2026; not related to financial reporting or policy disagreements.
- Cash severance of $463,000 paid bi-weekly over 12 months; plus pro-rata 2026 annual bonus payable March 2027.
- COBRA premium reimbursement for duration of severance; one-year non-solicitation and confidentiality covenants.
- Menezes signed a release of claims and non-disparagement; $45,000 liquidated damages for breach of confidentiality.
- Separation Agreement filed as Exhibit 10.1; executed May 15, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026037340/0001628280-26-037340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026037340/skin-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-037340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer